학술논문
Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFR-mutated NSCLC patient and successful management by adding ALK inhibitors: a case report.
Document Type
Journal Article
Author
Source
Subject
*CANCER treatment
*NON-small-cell lung carcinoma
*ANAPLASTIC lymphoma kinase
*EPIDERMAL growth factor receptors
*GENOTYPES
*CIRCULATING tumor DNA
*DELETION mutation
*DIAGNOSIS
*
*
*
*
*
*
*
Language
ISSN
1471-2407
Abstract